Microbial cell factories

被引:0
|
作者
Zhu, Xinna [1 ]
Dai, Zhubo [1 ]
Fan, Feiyu [1 ]
Zhao, Dongdong [1 ]
Bi, Changhao [1 ]
Zhang, Xueli [1 ]
机构
[1] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China
来源
CHINESE SCIENCE BULLETIN-CHINESE | 2023年 / 68卷 / 13期
关键词
synthetic biology; cell factories; metabolic engineering; metabolic regulation; gene editing; ESCHERICHIA-COLI; PRODUCTS; PATHWAY; IMPROVE;
D O I
10.1360/TB-2022-1106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Microbial cell factories are among the key subjects in synthetic biology research. Microbial cell factories produce bulk chemicals and natural products through renewable biomass resources. These green and clean biological manufacturing routes can supplement nonrenewable petrochemical resources and rare plant resources; thus, these routes can partially replace petrochemical manufacturing and plant extraction routes, which consume high amounts of energy and generate high pollution levels. The green routes provide an important method for society to address resource, energy and environmental problems. To successfully commercialize microbial cell factories, the regulatory mechanisms that microorganisms use to efficiently produce chemicals were investigated from two perspectives, including carbon metabolism and energy metabolism. Regarding carbon metabolism, a synthetic biology platform for enzyme mining was established, and the synthetic pathways of several triterpenoids were characterized using this platform. Furthermore, some cell factories that produce triterpenoids, such as hawthorn acid, corosolic acid and trichoparic acid, were created by Saccharomyces cerevisiae. In addition, precision pathway regulation technologies, including simultaneous modulation of multiple genes in chromosomes and glycosylase base editor (GBE), were developed and could improve the rate of xylose utilization by 3-fold compared with that of the control. The rate-limiting steps of the synthetic pathways for a series of chemicals were identified, and the rate-limiting enzymes were activated to increase the rate of chemical production by 2.5- to 600-fold; thus, the adaptation problems between enzyme parts and synthetic pathways were solved. When considering energy metabolism, four new modules of generating energy through glucose metabolism were designed according to the requirements of synthetic products; thus, the imbalance problems between the supply and the necessity of reducing equivalents in the synthetic pathway were solved. Based on the knowledge of the regulatory mechanisms for synthetic metabolism, efficient microbial cell factories were constructed by our research team to produce a series of chemicals. Technologies to microbially produce 14 chemicals have been licensed. Among these chemicals, four have been successfully commercialized, and the annual production of each chemical can reach over 10000 t. In addition, one company realized IPO. All these factors have promoted the industrial application of microbial cell factories. The future directions of research on microbial cell factories are discussed at the end of this paper. Most of the synthetic pathways of these cell factories are based on existing biosynthetic pathways in nature. However, for the vast majority of chemicals, the biosynthetic pathways are often unknown or do not occur in nature. How to microbially synthesize these chemicals is among the difficulties encountered when constructing a microbial cell factory. The principle of designing new pathways and new enzymes, the regulation of energy metabolism based on nonnatural coenzymes and the mechanism of chemical stress on cells can be studied in substance metabolism, energy metabolism, and physiological metabolism, respectively.
引用
收藏
页码:1626 / 1636
页数:11
相关论文
共 32 条
  • [21] Metabolic engineering of Saccharomyces cerevisiae for gram-scale diosgenin production
    Xu, Liping
    Wang, Dong
    Chen, Jing
    Li, Bo
    Li, Qingyan
    Liu, Pingping
    Qin, Ying
    Dai, Zhubo
    Fan, Feiyu
    Zhang, Xueli
    [J]. METABOLIC ENGINEERING, 2022, 70 : 115 - 128
  • [22] Construction of a carbon-conserving pathway for glycolate production by synergetic utilization of acetate and glucose in Escherichia coli
    Yu, Yong
    Shao, Mengyao
    Li, Di
    Fan, Feiyu
    Xu, Hongtao
    Lu, Fuping
    Bi, Changhao
    Zhu, Xinna
    Zhang, Xueli
    [J]. METABOLIC ENGINEERING, 2020, 61 : 152 - 159
  • [23] Zhang X L, 2021, Recombinant Escherichia coli for producing L-valine and application thereof, Patent No. [2020/137778, 2020137778]
  • [24] Zhang X L, 2020, Recombinant Escherichia coli for producing L-valine, and construction method and application of recombinant Escherichia coli, Patent No. [2020/137779, 2020137779]
  • [25] Zhang X L, 2011, PRC Patent, Patent No. [201110235159.8, 2011102351598]
  • [26] Zhang X L, 2020, PRC Patent, Patent No. [202011006212.2, 2020110062122]
  • [27] Zhang X L, 2014, USA Patent, Patent No. [10006063B2, 10006063]
  • [28] Imperfect guide-RNA (igRNA) enables CRISPR single-base editing with ABE and CBE
    Zhao, Dongdong
    Jiang, Guo
    Li, Ju
    Chen, Xuxu
    Li, Siwei
    Wang, Jie
    Zhou, Zuping
    Pu, Shiming
    Dai, Zhubo
    Ma, Yanhe
    Bi, Changhao
    Zhang, Xueli
    [J]. NUCLEIC ACIDS RESEARCH, 2022, 50 (07) : 4161 - 4170
  • [29] Zhao DD, 2021, NAT BIOTECHNOL, V39, P35, DOI 10.1038/s41587-020-0592-2
  • [30] Multiple strategies for metabolic engineering of Escherichia coli for efficient production of glycolate
    Zhu, Tong
    Yao, Die
    Li, Di
    Xu, Hongtao
    Jia, Shiru
    Bi, Changhao
    Cai, Jun
    Zhu, Xinna
    Zhang, Xueli
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (12) : 4699 - 4707